Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse
暂无分享,去创建一个
Keith M. Stantz | Naomi J. Halas | Mi-Ran Choi | Susan E. Clare | Rizia Bardhan | Harikrishna Nakshatri | Sunil Badve | N. Halas | S. Badve | H. Nakshatri | K. Stanton-Maxey | R. Bardhan | S. Clare | Mi-Ran Choi | Katie J. Stanton-Maxey | Ning Cao | K. Stantz | N. Cao | Rizia Bardhan
[1] Игорь Александрович Кутовой. ONCOLOGY OF THE NERVOUS SYSTEM , 2013 .
[2] M. Bynoe,et al. Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier , 2011, The Journal of Neuroscience.
[3] P. Steeg,et al. Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.
[4] Robia G. Pautler,et al. Nanoshells with Targeted Simultaneous Enhancement of Magnetic and Optical Imaging and Photothermal Therapeutic Response , 2009 .
[5] H. Gendelman,et al. Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1 , 2009, The Journal of Immunology.
[6] Naomi J Halas,et al. Fluorescence enhancement by Au nanostructures: nanoshells and nanorods. , 2009, ACS nano.
[7] G. Golomb,et al. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[8] N. Lin,et al. Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer , 2008, Cancer.
[9] Naomi J Halas,et al. Nanoshells made easy: improving Au layer growth on nanoparticle surfaces. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[10] Naomi J Halas,et al. Nanoscale control of near-infrared fluorescence enhancement using Au nanoshells. , 2008, Small.
[11] Jennifer Sturgis,et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.
[12] K. Hynynen,et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Steinberg,et al. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. , 2007, Cancer research.
[14] E. Winer,et al. Brain Metastases: The HER2 Paradigm , 2007, Clinical Cancer Research.
[15] Glenn P. Goodrich,et al. Plasmonic enhancement of molecular fluorescence. , 2007, Nano letters.
[16] V. Heinemann,et al. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. , 2006, Breast.
[17] C. Swanton,et al. Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab , 2006, Acta oncologica.
[18] E. Winer,et al. Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] R. Weil,et al. Breast cancer metastasis to the central nervous system. , 2005, The American journal of pathology.
[20] S. Lo,et al. Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases , 2005, Expert review of neurotherapeutics.
[21] A. Howell,et al. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer , 2004, British Journal of Cancer.
[22] Jill S Barnholtz-Sloan,et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] D. Begley,et al. ABC transporters and the blood-brain barrier. , 2004, Current pharmaceutical design.
[24] A. Twijnstra,et al. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma , 2004, Cancer.
[25] C. L. Graff,et al. Drug transport at the blood-brain barrier and the choroid plexus. , 2004, Current drug metabolism.
[26] E. Winer,et al. Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma , 2003, Cancer.
[27] W. Regine,et al. The Rationale for Adjuvant Whole Brain Radiation Therapy with Radiosurgery in the Treatment of Single Brain Metastases , 2003, Technology in cancer research & treatment.
[28] P. Wen,et al. Neurologic Complications of Cancer , 2003 .
[29] G. Barnett,et al. Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. , 2002, International journal of radiation oncology, biology, physics.
[30] Paul J. Williams,et al. A Bone‐Seeking Clone Exhibits Different Biological Properties from the MDA‐MB‐231 Parental Human Breast Cancer Cells and a Brain‐Seeking Clone In Vivo and In Vitro , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] A. Twijnstra,et al. Asymptomatic Brain Metastases (BM) in Small Cell Lung Cancer (SCLC): MR-imaging is Useful at Initial Diagnosis , 2000, Journal of Neuro-Oncology.
[32] M. Sands,et al. Behavior and Therapeutic Efficacy of β-Glucuronidase–Positive Mononuclear Phagocytes in a Murine Model of Mucopolysaccharidosis Type VII , 1999 .
[33] V. Budach,et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. , 1999, Journal of Clinical Oncology.
[34] P. Wen,et al. Management of brain metastases. , 1999, Oncology.
[35] Susan M. Chang,et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? , 1999, International journal of radiation oncology, biology, physics.
[36] J. Abkowitz,et al. Mature monocytic cells enter tissues and engraft. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] Naomi J. Halas,et al. Nanoengineering of optical resonances , 1998 .
[38] R. Sawaya,et al. Neurologic Complications of Cancer. , 1996 .
[39] Peter P. Edwards,et al. A new hydrosol of gold clusters. 1. Formation and particle size variation , 1993 .
[40] D. Hume,et al. Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier. , 1988, Journal of the National Cancer Institute.
[41] A. Walker,et al. Epidemiology of brain tumors , 1985, Neurology.
[42] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.
[43] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.
[44] W. Pardridge. The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.
[45] R. Meyermann,et al. Immune cell infiltration of intrinsic and metastatic intracranial tumours. , 2004, Anticancer research.
[46] A. Ardizzoni,et al. The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. , 2001, Critical reviews in oncology/hematology.
[47] M. Sands,et al. Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII. , 1999, Blood.
[48] A. Baiker,et al. A new hydrosol of gold clusters , 1993 .
[49] W. Stöber,et al. Controlled growth of monodisperse silica spheres in the micron size range , 1968 .